1,556 results on '"Teixeira, Mauro M."'
Search Results
2. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
3. Targeting PI3Kγ Pathway for Treating Dengue virus Infection
4. Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
5. FHL1 promotes chikungunya and o’nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design
6. Detection of Chikungunya Virus RNA in Cerebrospinal Fluid of Patients with Severe Neurological Disorders
7. Estimating the potential risk of transmission of arboviruses in the Americas and Europe: a modelling study
8. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
9. Neuromuscular defects after infection with a beta coronavirus in mice
10. Acute coronavirus infection triggers a TNF-dependent osteoporotic phenotype in mice
11. PI3K Isoforms in Cell Signalling and Innate Immune Cell Responses
12. Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients.
13. EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil
14. Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina
15. PAF signaling plays a role in obesity-induced adipose tissue remodeling
16. Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection
17. Exploiting the pro-resolving actions of glucocorticoid-induced proteins Annexin A1 and GILZ in infectious diseases
18. E3 Ubiquitin Ligase Smurf1 Regulates the Inflammatory Response in Macrophages and Attenuates Hepatic Damage during Betacoronavirus Infection.
19. Natural product pharmacology: the British Journal of Pharmacology perspective.
20. Blame the signaling: Role of cAMP for the resolution of inflammation
21. Estrogen protects dental roots from orthodontic-induced inflammatory resorption
22. Glucocorticoid-induced leucine zipper modulates macrophage polarization and apoptotic cell clearance
23. Decreased expression of neuronal nitric oxide synthase contributes to the endothelial dysfunction associated with cigarette smoking in human
24. Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production
25. Evidence supporting correlation between aging and dengue severity: A retrospective analysis on the 2010 dengue outbreak in Brazil
26. Association Between Zika Virus Microcephaly in Newborns With the rs3775291 Variant in Toll-Like Receptor 3 and rs1799964 Variant at Tumor Necrosis Factor-α Gene
27. IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis
28. In-depth characterization of congenital Zika syndrome in immunocompetent mice: Antibody-dependent enhancement and an antiviral peptide therapy
29. The protective arm of the renin‐angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
30. Mediators of the Resolution of the Inflammatory Response
31. Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
32. Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
33. Antibacterial and Antiviral Properties of Chenopodin-Derived Synthetic Peptides
34. Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review.
35. Medicinal plants and their potential use in the treatment of rheumatic diseases
36. Contributors
37. Protective Effect of Bovine Milk Extracellular Vesicles on Alveolar Bone Loss
38. Influence of previous Zika virus infection on acute dengue episode
39. Treatments for dengue: a Global Dengue Alliance to address unmet needs
40. Neuronal nitric oxide synthase contributes to the normalization of blood pressure in medicated hypertensive patients
41. Secondary Streptococcus pneumoniae infection increases morbidity and mortality during murine cryptococcosis
42. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
43. The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1
44. 2-Phthalimidethanol and 2-phthalimidethyl nitrate inhibit mechanical allodynia, neutrophil recruitment and cytokine and chemokine production in a murine model of articular inflammation
45. Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1
46. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes
47. Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo
48. Protective Effect of Bovine Milk Extracellular Vesicles on Alveolar Bone Loss.
49. Evaluating the effects of refined carbohydrate and fat diets with acute ethanol consumption using a mouse model of alcoholic liver injury
50. Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.